MARKET

RMD

RMD

Resmed
NYSE
218.30
-0.16
-0.07%
After Hours: 218.30 0 0.00% 17:00 09/30 EDT
OPEN
219.26
PREV CLOSE
218.46
HIGH
223.13
LOW
217.71
VOLUME
521.20K
TURNOVER
0
52 WEEK HIGH
275.66
52 WEEK LOW
189.05
MARKET CAP
31.96B
P/E (TTM)
41.17
1D
5D
1M
3M
1Y
5Y
Hopeful Golden Cross Forms On ResMed's Chart
If history is any guide, there may be good fortune ahead for shares of ResMed (NYSE:RMD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
Benzinga · 09/22 15:14
Insider Sell: Resmed
Insider Sell: Resmed
MT Newswires · 09/19 07:27
Citigroup Upgrades ResMed to Buy
Citigroup analyst John Deakin-Bell upgrades ResMed (NYSE:RMD) from Neutral to Buy.
Benzinga · 09/08 19:14
EXPLAINER-What is the impact of Philips' recall of sleep apnea devices?
EXPLAINER-What is the impact of Philips' recall of sleep apnea devices?
Reuters · 08/21 12:00
Research Alert: CFRA Maintains Sell Opinion On Shares Of Resmed Inc.
Research Alert: CFRA Maintains Sell Opinion On Shares Of Resmed Inc.
MT Newswires · 08/15 14:59
Competitor Recall Continues To Show Opportunities For ResMed
ResMed Inc (NYSE: RMD) posted Q4 sales of $914.7 million, +4% Y/Y (+8% on a constant currency basis), beating the consensus of $912.97 million. Adjusted EPS reached $1.49, up from $1.35 a year ago. The company also increased its quarterly dividend to $0.44...
Benzinga · 08/12 22:34
ResMed (RMD) Q4 Earnings Beat Estimates, Gross Margin Up
ResMed (RMD) posts better-than-expected Q4 results with continued strength in sleep and respiratory care devices sales performance.
Zacks · 08/12 19:34
ResMed downgraded at JPMorgan and RBC despite earnings beat
ResMed (NYSE:RMD) traded lower Friday despite posting better than expected f...
Seekingalpha · 08/12 16:27
More
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices and cloud-based software informatics solutions.

Webull offers kinds of ResMed Inc. stock information, including NYSE:RMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RMD stock methods without spending real money on the virtual paper trading platform.